8.225USD+0.55%Mkt Cap: 55.41M USDP/E: —Last update: 2026-05-26
Instil Bio, Inc., a biopharmaceutical company, focuses on identifying and advancing therapeutic opportunities. It seeks to in-license or acquire and develop additional novel therapeutic candidates in diseases with signif…
Industry Peers
Biotechnology110.61BUSDP/E 25.8
105.81BDKKP/E 20.4
66.47BUSDP/E 15.5
46.56BEURP/E 30.5
43.89BEURP/E 36.5
39.41BUSDP/E 74.0
32.84BUSD—
32.05BSEKP/E 47.4
Indicators:|
Key Statistics
Company
Market Cap55.41M USD
Enterprise Value—
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-71.37M USD
Revenue/Share—
Last Price8.225 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees17
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.55
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B0.48
EPS (TTM)-7.00
EPS (Forward)-14.64
52W Range
5.6707% of range42.79
52W High42.79 USD
52W Low5.670 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-62.68%
ROA-35.07%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-36.62M USD
CapEx (TTM)10.00M USD
FCF Margin—
FCF Yield—
Net Debt—
Net Debt/EBITDA—
Balance Sheet
Debt/Equity0.75
Current Ratio—
Quick Ratio—
Book Value/Sh16.79 USD
Cash/Share—
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:20
Split DateDec 8, 2023
Analyst Consensus
Rating3.0 (Hold)
Target (Mean)7.000 USD
Target Range7.000 USD – 7.000 USD
# Analysts1
Ownership
Shares Out.6.78M
Float3.62M
Insiders6.29%
Institutions62.20%
Short Interest
Short Ratio10.4d
Short % Float6.47%
Short % Out.3.84%
Shares Short260.42K
Short (prev mo.)414.92K
Technical
SMA 508.250 (-0.3%)
SMA 20013.52 (-39.2%)
Beta—
S&P 52W Chg28.31%
Avg Vol (30d)29.84K
Avg Vol (10d)40.30K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—